Register for DSEC’s complimentary On-Demand webinar by submitting your information below.

On-Demand Webinar

Is There a Role for a Chief Safety Officer in Big Pharma, and How Should it be Defined?
Originally took place place on October 8, 2009.

John Ferguson, MD, Vice President & Global Head, Pharmacovigilance & Medical Safety, Novartis Vaccines & Diagnostics made the presentation which addressed the following:

• How is safety assessment currently integrated across research, development and post marketing?
• How we can inspire increased dialogue across an organization to improve safety predictivity and risk management.
• What new techniques or tools are being utilized to better integrate safety assessment across the organization?
• Should safety assessment and risk management be integrated under one umbrella as is the financial role under the Chief Financial Officer?
• How can safety risks and risk mitigation be better communicated to the public before, during and after launch of new pharmaceuticals?

First Name:
Last Name:
Title:
Function/Dept:
Company:
Phone:
E-Mail: